US Inflation

Team “transitory” probably continues to feel pretty good, based on the US CPI print out overnight.

Underlying core momentum was a little higher, enough to give the not-so-transitory something to latch on to, but the key takeaway is the annualised 1m and 3m data, which shows the pace of acceleration has declined markedly.


Our view, aligned to team transitory, has been predicated on the componentry. All of the gains were coming from a relatively narrow set of sectors (new and used vehicles, airlines, hotels), and those, as the below graph shows, are now moderating.

Taper will occur, as it has to, and the US (ex COVID) is strong enough to see higher rates down the track (which is distinctly separate from tapering). We think that’s a meaningful negative to secular growth stocks (tech, fintech, health), and some cyclically high flying sectors (discretionary) where valuations are stretched.

Likewise, that will mean shorter term losses on long duration fixed income securities. As such, we are modestly underweight shares, and bonds, at the diversified portfolio level, with overweights to cash and alternative strategies (equity market neutral, global macro, absolute return via alt risk premia [classic fama french factors]).

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.